Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Next-generation stem cell therapy poised to enter EU market

Nature Biotechnology volume 33, pages 224–225 (2015)Cite this article

Subjects

This article has been updated

“I consider it a very important step towards worldwide implementation of a very promising technology,” says Tor Paaske Utheim, an ophthalmologist at the Oslo University Hospital in Norway, who has carried out similar procedures but is not involved in Holoclar. “It is also a very important step in the right direction for other cell therapies.”

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 28 April 2015

    In the version of this article initially published, the byline was omitted in the HTML version. The error has been corrected in the HTML version of the article.

Author information

Authors and Affiliations

  1. Somerville, Massachusetts

    Elie Dolgin

Authors
  1. Elie Dolgin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dolgin, E. Next-generation stem cell therapy poised to enter EU market. Nat Biotechnol 33, 224–225 (2015). https://doi.org/10.1038/nbt0315-224

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0315-224

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing